Female infertility
Conditions
Interventions
Recombinant human follicle-stimulating hormone for injection Observation group:None
Sponsors
The Fourth Hospital of Hebei Medical University
Eligibility
Sex/Gender
Female
Age
20 Years to 38 Years
Inclusion criteria
Inclusion criteria: 1. Female age: 20-38 years old (including the boundary value); 2. The basal progesterone level is normal 3. Meet the indications for IVF/ICSI- embryo transfer; 4. Voluntarily sign the informed consent form
Exclusion criteria
Exclusion criteria: 1. Have a history of allergy to rFSH or excipients of such drugs; 2. Hypothalamic or pituitary tumors; 3. Ovarian enlargement or cysts not caused by polycystic ovary syndrome; 4. Gynecological bleeding of unknown cause; 5. Ovarian, uterine or breast cancer; 6. Individuals suffering from known severe mental illnesses or who cannot understand the purpose, methods, etc. of this clinical trial, as well as those who do not follow the research procedures
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Total dose of recombinant human follicle-stimulating hormone for injection;The number of days of recombinant human follicle-stimulating hormone stimulation for injection;The proportion of subjects who need to adjust the dose of recombinant human follicle-stimulating hormone for injection;Oestradiol concentration and endometrial thickness on the day of HCG administration;Biochemical pregnancy rate;Clinical pregnancy rate; | — |
Primary
| Measure | Time frame |
|---|---|
| The number of oocytes retrieved; | — |
Countries
China
Contacts
Public ContactZhang Na
The Fourth Hospital of Hebei Medical University
Outcome results
None listed